NCT07001696 Combining Chest X-Ray and Arterial Blood Gas Findings to Predict Need for Mechanical Ventilation in Critically Ill Patients
| NCT ID | NCT07001696 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Zagazig University |
| Condition | Respiratory Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,160 participants |
| Start Date | 2025-06-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,160 participants in total. It began in 2025-06-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective cross-sectional study aims to develop and validate a machine learning model that combines chest X-ray findings with arterial blood gas (ABG) analysis to assess the necessity for mechanical ventilation in critically ill adult patients. Conducted at Zagazig University Hospitals, the study seeks to improve clinical decision-making by integrating radiological and biochemical data using artificial intelligence. The model's predictive performance will be evaluated against standard clinical assessments.
Eligibility Criteria
Inclusion Criteria: Critically ill adult patients aged 18 years or older. Patients assessed to require mechanical ventilation. Control group: Age- and sex-matched critically ill patients not requiring mechanical ventilation. Availability of both chest X-ray and arterial blood gas (ABG) analysis at the time of evaluation. Exclusion Criteria: Patients with missing or incomplete data (e.g., absent chest X-ray or ABG results). Patients with chronic lung diseases unrelated to the current admission (e.g., COPD, pulmonary fibrosis). Pregnant females.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07001696 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Respiratory Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07001696 currently recruiting?
Yes, NCT07001696 is actively recruiting participants. Contact the research team at OIAbdelhamid@medicine.zu.edu.eg for enrollment information.
Where is the NCT07001696 trial being conducted?
This trial is being conducted at Zagazig, Egypt.
Who is sponsoring the NCT07001696 clinical trial?
NCT07001696 is sponsored by Zagazig University. The trial plans to enroll 2,160 participants.